Viborg, Denmark

Jørgen Berntsen

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jørgen Berntsen: Innovator in Embryo Development Assessment

Introduction

Jørgen Berntsen is a notable inventor based in Viborg, Denmark. He has made significant contributions to the field of embryo development assessment through his innovative patent. His work focuses on improving the understanding of developmental events in embryos, which can have profound implications in reproductive technology.

Latest Patents

Jørgen Berntsen holds a patent titled "Methods and apparatus for assessing embryo development." This patent describes a method for processing a series of images of an embryo to determine estimated timings of developmental events. The method involves determining feature information for each image, establishing machine-learned classifiers, and applying these classifiers to assess the likelihood of images being associated with developmental events. Additionally, the method includes determining an indication of a confidence estimate for the timings. This innovative approach enhances the accuracy of embryo development assessments.

Career Highlights

Throughout his career, Jørgen Berntsen has worked with prominent companies in the reproductive technology sector. Notably, he has been associated with Vitrolife A/S and Unisense Fertilitech A/S. His experience in these organizations has allowed him to contribute to advancements in embryo assessment technologies.

Collaborations

Jørgen has collaborated with esteemed colleagues, including Jens Rimestad and Michael Sass Hansen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of embryo development.

Conclusion

Jørgen Berntsen's contributions to embryo development assessment through his patent and collaborations highlight his role as an innovator in reproductive technology. His work continues to influence the field and improve outcomes in embryo assessment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…